Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Amortizatization of Intangibles: 2020-2024

Historic Amortizatization of Intangibles for Black Diamond Therapeutics (BDTX) over the last 5 years, with Dec 2024 value amounting to $3.8 million.

  • Black Diamond Therapeutics' Amortizatization of Intangibles rose 444.22% to $4.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $3.8 million for FY2024, which is 222.15% up from last year.
  • Black Diamond Therapeutics' Amortizatization of Intangibles amounted to $3.8 million in FY2024, which was up 222.15% from $1.2 million recorded in FY2023.
  • In the past 5 years, Black Diamond Therapeutics' Amortizatization of Intangibles registered a high of $3.8 million during FY2024, and its lowest value of -$536,000 during FY2022.
  • Over the past 3 years, Black Diamond Therapeutics' median Amortizatization of Intangibles value was $1.2 million (recorded in 2023), while the average stood at $1.5 million.
  • In the last 5 years, Black Diamond Therapeutics' Amortizatization of Intangibles plummeted by 124.52% in 2022 and then surged by 319.03% in 2023.
  • Over the past 5 years, Black Diamond Therapeutics' Amortizatization of Intangibles (Yearly) stood at $1.7 million in 2020, then climbed by 26.72% to $2.2 million in 2021, then slumped by 124.52% to -$536,000 in 2022, then surged by 319.03% to $1.2 million in 2023, then surged by 222.15% to $3.8 million in 2024.